Company profile
Psyomics Ltd
Psyomics
Our technology gets to the root of mental health, helping more people find the best support for their needs, whenever they need it.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Development of diagnostic device to differentiate between bipolar and unipolar depression
1 Nov 2017 to 30 Apr 2019
Bipolar disorder affects 2.4m people in the UK alone and has an estimated prevalence of around 2% globally, yet 40% of patients with bipolar disorder are misdiagnosed with depression and it takes an average of 7.5 years for the correct diagnosis to be reached. This leads to ineffective treatments, increased suicide risk, antidepressant-induced mania and h...
PsyOmics Quantified Health Solution
1 Apr 2016 to 31 Dec 2016
PsyOmics Ltd is a biotech company that is working in collaboration with the Cambridge Centre for Neuropsychiatric Research (CCNR) to deliver improved prevention, diagnosis and treatment of psychiatric conditions. We aim to: (i) Improve treatment by providing contract research services to support clinical trials for psychiatric treatment (ii) Improve diagn...